Global Drug Testing Market Report 2022

New York, July 29. 2022 (GLOBE NEWSWIRE) — Announces Release of “Drug Screening Global Market Report 2022” –

The global drug testing market is expected to grow from $5.80 billion in 2021 to $6.58 billion in 2022 at a compound annual growth rate (CAGR) of 13.53%. The drug testing market is expected to reach $10.66 billion in 2026 at a compound annual growth rate (CAGR) of 12.81%.

The drug testing market includes sales of drug testing solutions and related services by entities (organizations, individual merchants and partnerships) that refer to an approach used for drug testing, identified and optimized for clinical trials used in the analysis of blood, urine, hair or saliva to detect the presence of chemicals and pollutants and other illicit substances left in the body as a result of drug use. Screening methods range from lower performance tests such as microscopic observation to high performance observation.

Drug screens come in many shapes and sizes and are used for multiple applications.

Major types of drug testing products include rapid test devices, consumables, and others. Rapid test devices refer to easy-to-use drug screening devices that provide results faster than the standard traditional lab test.

The different samples used in drug testing include oral fluid sample, hair sample, urine sample, breath sample, and others. They are used in drug testing labs, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools and colleges.

North America was the largest region in the drug testing market in 2021. Asia-Pacific is expected to be the fastest growing region during the forecast period.

Regions covered in the Drug Testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Drug Testing Market research report is one of a series of new reports that provide statistics on the Drug Testing market, including the global Drug Testing industry market size, regional shares, competitors holding Drug Testing market share, detailed Drug Testing market segments, market trends and opportunities. , and any other data you may need to thrive in the drug testing industry. This Drug Testing Market research report provides a comprehensive perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increasing consumption of drugs and alcohol is driving the growth of the drug testing market. Drug addiction is a disease that affects a person’s brain and behavior, resulting in the inability to control the use of a legal or illegal drug or medication.

Substances such as alcohol, marijuana and nicotine are also considered drugs. As drug addiction and alcoholism increase, the risks of disease are higher, triggering the need for drug testing.

For example, in June 2019 and 2020, according to a report published by the United Nations Office on Drugs and Crime (UNODC), 35 million people worldwide suffer from drug use disorders and need treatment services. The seriousness and complexity of the world drug situation is increasing, revealing that the number of people who use drugs is now 30% higher than in 2009.

The effects of the pandemic are also increasing drug-related risks, with cannabis use by young people increasing up to four times in some parts of the world. Hence, the increasing consumption of drugs and alcohol is driving the growth of the drug testing market.

The development of innovative products is a key trend that is gaining popularity in the drug testing market. Major companies operating in the drug testing market are focusing on providing innovative products to meet the growing industry demand and strengthen their position in the market.

Additionally, due to COVID, there has been a sudden shift in the approach to drug testing, which has changed testing methodologies and driven innovation and new product development by companies. Companies are striving to develop new products such as a new drug test that is more effective and can be widely used by laboratories.

For example, in April 2019, Thermo Fisher Scientific, a US-based laboratory supplies and biotechnology company, introduced a new drug addiction test with supporting calibrators and controls. Named CEDIA Mitragynine (Kratom) Assay, it can be performed on widely used clinical chemistry. analyzers, allowing a wide range of laboratories to test for the presence of Kratom.

This test is only intended for use in criminal justice and forensics.

In January 2020, StemBioSys, Inc., a Texas-based company involved in the development, manufacture, and distribution of life science tools, acquired a majority stake in CarTox, Inc. for an undisclosed amount. This acquisition is expected to strengthen the company’s product portfolio in the drug screening and toxicology sector and contribute to its strategy to expand its commercial presence around the world. CarTox, Inc. is a Michigan-based developer and manufacturer of drug toxicology and screening solutions.

Countries covered in the Drug Testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the United Kingdom and the United States.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


Comments are closed.